Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A series of experiments were conducted in adult ewes to delineate the release profile of activin A and its relationship to other cytokines following an i.v. injection of the bacterial cell wall component, lipopolysaccharide (LPS). Following this challenge, plasma activin A increased rapidly and appeared to be released in a biphasic manner, slightly preceding the release of tumour necrosis factor-alpha (TNFalpha) and before elevation of interleukin (IL)-6 and follistatin levels. The concentration of activin A was correlated with body temperature during the response to LPS. A second experiment compared cytokine concentrations in matched blood and cerebrospinal fluid (CSF) samples. This revealed that activin A was not released centrally in the CSF following a peripheral LPS injection, nor was TNFalpha or the activin binding protein, follistatin, but IL-6 showed a robust elevation. In a third experiment, the stimulus for activin A release was examined by blocking prostaglandin synthesis. Flurbiprofen, a prostaglandin synthesis inhibitor, effectively attenuated the fever response to LPS and partly inhibited cortisol release, but the cytokine profiles were unaffected. Finally, the bioactivity of TNFalpha and/or IL-1 was blocked using soluble receptor antagonists. These treatments did not affect the initial release of activin A, but blockade of TNFalpha depressed the second activin peak. These studies define more rigorously the release of activin A into the circulation following acute inflammatory challenge. The response is rapid and probably biphasic, independent of prostaglandin- mediated pathways and does not depend upon stimulation by TNFalpha or IL-1. The data suggest that activin A release is an early event in the inflammatory cascade following the interaction of LPS with its cellular receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. J., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., et al. (1999) · Nature Cell Biology · doi:10.1038/12971 · Cited by 911 · cited 1×
“Intriguingly, targeted disruption of Smad3, common to both activin and TGF , results in impaired inflammatory responses (Ashcroft et al. 1999, Yang et al. 1999).”
BackgroundImpaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677 · cited 1×
“…is the ordered and structured release of pro-inflammatory cytokines such as tumour necrosis factor- (TNF ), interleukin (IL)-1 and IL-6, classic early release cytokines which stimulate prostaglandin production both peripherally and centrally (Kluger 1991, Ushikubi et al. 1998, Ek et al. 2001).”
BackgroundFunctional analysis of activins during mammalian development
Matzuk, M. M., Kumar, T. R., Vassalli, A., Bickenbach, J. R., Roop, D. R., Jaenisch, R., & Bradley, A. (1995) · Nature · doi:10.1038/374354a0 · Cited by 578 · cited 1×
“…remains elusive due to the difficulty in generating models where the activin release is blocked by pharmacological means (such as concurrent administration of follistatin) or through transgenic approaches (for example, the perinatal lethality of the activin A knockout mouse (Matzuk et al. 1995)).”
Background
Cited by
Activins and Inhibins: Roles in Development, Physiology, and Disease
Namwanje, M., & Brown, C. W. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021881 · Cited by 294
Jones, K. L., Mansell, A., Patella, S., Scott, B. J., Hedger, M. P., de Kretser, D. M., & Phillips, D. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705971104 · Cited by 280
Self-citationRoles of activin in tissue repair, fibrosis, and inflammatory disease
WERNER, S., & ALZHEIMER, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.001 · Cited by 209
de Kretser, D. M., Bensley, J. G., Pettilä, V., Linko, R., Hedger, M. P., Hayward, S., Allan, C. A., McLachlan, R. I., Ludlow, H., & Phillips, D. J. (2013) · Critical Care · doi:10.1186/cc13093 · Cited by 39
“Further, follistatin administration prior to a lethal LPS injection was found to halve the mortality in mice [15].”
BackgroundSelf-citation
Metadata
- Authors
- Jones, K., de Kretser, D., Clarke, I., Scheerlinck, J., & Phillips, D.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2004-07-01
- Volume
- 182
- Issue
- 1
- Pages
- 69-80
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2117143834
- Cited by
- 68
- References
- 3
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. https://app.cochat.ai/papers/10.1677/joe.0.1820069
- The paper
- Jones, K., de Kretser, D., Clarke, I., Scheerlinck, J., & Phillips, D. (2004). Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. Journal of Endocrinology. https://doi.org/10.1677/joe.0.1820069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.